Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans
Adapting Behavioral Activation to Improve Mental Health Outcomes and Reduce Suicide Risk During the Military Transition
4 other identifiers
interventional
40
1 country
1
Brief Summary
The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be developed as part of this study, will meet participant recruitment, retention, and satisfaction benchmarks (primary outcomes) and show positive preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes (secondary outcomes). The specific aims of this study are to:
- 1.Develop a small-group, peer-led, cross-cutting prevention program for newly separated veterans (NSVs) called THRiVE and
- 2.Evaluate the feasibility, acceptability, and preliminary effects of the THRiVE program on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Start
First participant enrolled
July 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
January 21, 2026
January 1, 2026
1.3 years
January 9, 2025
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Participant recruitment rate
The percentage of NSVs who are determined to be eligible based on their eligibility assessment and choose to enroll. It is anticipated that recruitment will begin May 2025 and enrollment of the final participant will be July 2026 (a recruitment/enrollment window of 14 months).
14 months
Participant retention rate
The percentage of participants who attend at least 4 of the 6 planned total THRiVE sessions
Through completion of the THRiVE group, an average of 2 months
Client Satisfaction Questionnaire-8
Participant self-reported satisfaction with the THRiVE program at post-THRiVE. Possible scale scores range 8 to 32, with higher scores indicating greater program satisfaction.
At completion of the THRiVE group, an average of 2 months
Secondary Outcomes (8)
Generalized Anxiety Disorder-7
Through study completion, an average of 5 months
PTSD Checklist for DSM-5
Through study completion, an average of 5 months
Alcohol Use Disorders Identification Test
Through study completion, an average of 5 months
Drug Abuse Screening Test
Through study completion, an average of 5 months
Patient Health Questionnaire-9
Through study completion, an average of 5 months
- +3 more secondary outcomes
Study Arms (1)
THRiVE
EXPERIMENTALInterventions
Six (6) total weekly, 90-minute, small-group, peer-led sessions delivered virtually
Eligibility Criteria
You may qualify if:
- Be a United States military veteran
- Have separated/retired from the military no more than 12 months prior to study enrollment
- Be at least 18 years old
- Have access to the internet; a desktop computer, laptop, tablet, or other "smart" device with video camera, speakers, and microphone; and a private place from which to attend THRiVE sessions
- Reside and complete all study activities within the United States
You may not qualify if:
- Endorse lifetime manic, hypomanic, or psychotic episodes
- Screen positive for moderate or high acute risk for suicide
- Screen positive for more than minimal risk for other-directed violence
- Are receiving or plan to receive BA therapy for any mental health condition between enrollment and the 3-month follow-up assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RTI Internationallead
- U.S. Army Medical Research Acquisition Activitycollaborator
Study Sites (1)
RTI International
Durham, North Carolina, 27713, United States
Related Publications (1)
Blakey SM, Vandermaas-Peeler JR, Counts J, Croxford J, Rae Olmsted KL, Gant P, Elbogen EB, Asman K. Bringing veteran mental health promotion and suicide prevention efforts upstream: The THRiVE study protocol. Contemp Clin Trials. 2025 Nov;158:108100. doi: 10.1016/j.cct.2025.108100. Epub 2025 Oct 4.
PMID: 41052716DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shannon M Blakey, PhD
RTI International
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Clinical Psychologist
Study Record Dates
First Submitted
January 9, 2025
First Posted
January 16, 2025
Study Start
July 30, 2025
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
October 31, 2026
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share